REGN727(SAR236553)
R727-CL-1001
Phase 1 small_molecule completed
Quick answer
REGN727(SAR236553) for Hypercholesterolemia is a Phase 1 program (small_molecule) at REGENERON PHARMACEUTICALS, INC. with 1 ClinicalTrials.gov record(s).
Program details
- Company
- REGENERON PHARMACEUTICALS, INC.
- Indication
- Hypercholesterolemia
- Phase
- Phase 1
- Modality
- small_molecule
- Status
- completed